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Summary: The serum protein patterns of 38 patients with alcoholic liver cirrhosis were studied and compared
with those of 15 patients with cryptogenic cirrhosis and of 18 normal volunteers. Serum prealbumin and
albumin were significantly lowered in alcoholic liver cirrhosis in comparison with the normals. In liver
cirrhosis, the four acute phase reactants, c^-antiproteinase, orosomucoid, haptoglobin and caeruloplasmin,
showed a pattern in serum, in which arantiproteinase was increased, orosomucoid and haptoglobin were
decreased, and caeruloplasmin was normal. Immunoglobulins G, A and M were significantly elevated. IgA
was significantly more elevated in patients with alcoholic disease than in patients with cryptogenic cirrhosis.
The constfüctioü of a surgical portal-systemic shunt resulted in a significant decrease in serum concentrations
of the acute phase reactants, while prealbumin, albumin and immunoglobulins were unaffected.
Introduction , « , , , . . ,
a meso-caval shunt or had undergone shunt surgery.
Liver cirrhosis with portal hypertension is accom- We wanted to elucidate the extent to which these
panied by changes in the concentration of proteins in patients show derangements in serum proteins com-
serum (l, 2). A fall in albumin concentration has been pared with healthy controls, and whether the serum
shown to be related to the patieiit's life expectancy protein pattern is influenced by a meso-caval shunt
(3). Thus, it may be important to avoid further der- that reduces nutrient hepatic blood flow.
angements in serum proteins when institutiiig therapy
for bleeding secondary to the portal hypertension.
Interppsition meso-caval shunt1) surgery results in a Materials and Methods
reduction of portal blood flow to the liver and in- . 1 ^ - 0 0\ . , . , . ,.,.
 r Serum protein patterns were analysed m 38 nonoperated pa-
creased portal-systemic shuntmg, The inability of a
 tients ^  biopsy-proven alcoholic cirrhosis and a history of
portal^systemic shunt to prolong survival (4) might endoscopicajly verified bleeding oesophageal varices. For com-
be .explained by this reduction of nutrient blood flow ^rison'' !f «onop^ated patients with ciyptogenic cirrhosis and
*
 J
- . 18 normal volunteers were exammed. These subjects did not
to the liver causing further serum protein changes.
 differ statistically from the patients with alcoholic liver cirrhosis
. . in sex or age distribution. Standard serum liver tests in the
The present stüdy was performed on patients with patients are shown in tablel.
liver cirrhosis, portal hypertension and bleeding oes- _. . ,. .. . .. . ...
 r
' ? J* . ö ' The serum protein pattern was studied m ten patients with liver
ophageal vances, who where possible candidates for cirrhosis who were investigated before, and six to twelve months
following, the construction of an interposition meso-caval
—~~~ ' shunt. A 14 mm Gore-Tex graft was used. Six of these patients
J) Surgieal shunt created for passage of venous blood from the had alcoholic, two cryptogenic and two primary biliary cirrho-
superior mesenteric vein to the caval vein = mesenterico- sis. None of these patients had clinically obvious ascites before
caval (meso-caval) shunt. or after the meso-caval shunt.
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Preoperatively the patients were admitted in a bleeding-free
interval for rouline examinalion. Portal hypertension, defmed
äs a portal pressure exceeding 25 cm of water above atmospheric
pressure, was found by portal pressure monitoring through a
percutaneously introduced transhepatic portal catheter. In the
operated patients, the patency of the meso-caval shunt was
confirmed on angiography.
Following at least four days of alcoholic abstincence, with
regulär hospital food containing 80 gram.of protein, overaight
fasting blood samples were obtained from an antecübital vein.
Serum bilirubin levels were analysed by the method of Nosslin
(5). Serum catalytic activity concentrations of alanine
aminotransferase2), alkaline phosphatase2), aspartate
aminotransferase2) and -glutamyl transferase2) were assayed
according to the Committee of Enzymes of the Scandinavian
Society of Clinical Chemistry and Clinical Physiology (6, 7).
Immunoassay methods äs described by Laurell (8) were used
to determine the serum proteins, prealbumin, albumin, QI-
antiproteinase, orosomucoid, haptoglobin, caeruloplasmin and
the immunoglobins G, A and M (IgG, IgA, IgM).
A typical pattern of acute phase proteins was defmed according
to Carlson & Eriksson (9): arantiproteinase concentration mi-
nus orosomucoid concentration ^5%, and ai-antiproteinase
concentration minus haptoglobin concentration ^20%.
Statistical evaluation was performed using the Mann Whitney
rank sum test for, unpaired data and the Wilcoxon signed rank
test for paired data. A p-value < 0.05 was considered signifi-
cant.
Results
Serum proteins in alcoholic cirrhosis (tab. 2)
Serum prealbumin concentrations were significantly
lower in the patients when compared with the refer-
ence population. All cirrhotic prealbumin values, ex-
cept one, were below the inferior reference limit.
Serum albumin concentrations were significantly low-
ered in the patients, with 84% of the values below
the inferior reference limit.
The four acute phase reactants showed different pat-
terns. at-Antiproteinase was significantly elevated
while orosomucoid and haptoglobin were significantly
decreased. Caeruloplasmin was normal in most pa-
tients. The pattern of acute phase reactants indicative
of liver disease äs defmed by Carlson & Eriksson (9)
was present in 72% of the cases.
The three immunoglobulins were all significantly ele-
vated in the patients; IgG and IgA being the most
frequently abnormal.
2) Enzymes:
Alanine aminotransferase (L-alanine-2-oxoglutarate amino-
transferase EC 2.6.1.2).
Alkaline phosphatase (orthophosphoric monoester phos-
phohydrolase, alkaline Optimum EC 3.1.3.1).
Aspartate aminotransferase (L-aspartate-2-oxoglutarate
aminotransferase EC 2.6.1.1).
-Glutamyltransferase ((y-glutamyl)-peptide: amino acid -
glutamyl transferase EC 2.3.2.2).
Serum
(tab. 2)
proteins in cryptogenic cirrhosis
These patients showed the same pattern äs the subjects
with alcoholic cirrhosis, except for IgA, which was
significantly more elevated in the latter.
Effects of a meso-caval shunt on serum pro-
teins (tab. 3)
The prealbumin and albumin, produced by the liver,
were not affected. Fürthermore, immunoglobulins did
not change significantly. The acute phase reactants,
however, all decreased significantly föllowing shunt
surgery.
Biscussion
A meso-caval shunt does not seem to influence hepatic
protein production within six to twelve months, since
prealbumin and albumin serum concentrations are
unaffected postoperatively. The shunt üsually dimin-
ishes ascites production and subsequently the loss of
proteins into the peritoneal cavity is reduced. This
might obscure serum changes due to diminished he-
patic protein production. However, none of these
patients had clinically obvious ascites before or after
the meso-caval shunt.
Cirrhotic patients üsually exhibit increased serum con-
centrations of ai-antiproteinase, and decreased con-
centrations of orosomucoid and haptoglobin, while
caeruloplasmin is normal (9). The low concentrations
of serum haptoglobin found in liver cirrhosis are
probably at least partly due to the increased break-
down of erythrocytes in the enlarged spieen of patients
with portal hypertension (10). An interesting obser-
vation is the significant fall in serum concentrations
of the four acute phase reactants föllowing shunt
surgery. Increased shunting of endotoxins from the
gut into the general circulation might theoreticälly
cause release of interleukin-1 from activated macro-
phages, with ensuing induction of hepatic production
of the acute phase reactants (11, 12). Possibly, the
diminished nutrient portal blood flow to the liver,
föllowing shunt surgery, counteracts the expected in-
crease and causes the decreased serum concentrations
by reducing hepatic production.
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Tab. 1. Serum liver tests in the cirrhotic patients. Mediän and ränge.
Alcoholic cirrhosis Cryptogenic cirrhosis Reference ränge
Number of patients
Number of men
Age (years)
Bilirubin ( / )
Alkaline phosphatase (ukat/1)
-Glutamyltransferase fckat/l)
Aspartate aminotransferase ( kat/l)
Alanine aminotransferase ^kat/l)
38
33
57 (30-71)
25(10-136)
5.0(2.9-13.0)
2.4 (0.6-7.7)
0.8(0.4-5.3)
0.3(0.1-2.4)
15
6
64(33-76)
25.5 (10-500)
11.1 (2.4-39.0)
3.2(0.2-8.7)
1.2(0.4-3.1)
0.6 (0.2-2.0)
3-20
0.8-4.6
< 1.0
< 0.7
< 0.7
Tab. 2. Serum proteins (g/l) in normal subjects (n
Mediän and ränge.
18) and in patients with alcoholic (n = 38) or cryptogenic (n = 15) cirrhosis.
Normal Alcoholic Cryptogenic
Prealbumin 0.30 (0.19-0.37)
Albumin 42 (37-46)
,-Antiproteinase 1 .4 (1 .2 - 1 .7)
Orosomucoid 0.9 (0.7 -1.1)
Haptoglobin 1.0(0.3-1.7)
Caeruloplasmin 0.3 (0.2-0.5)
IgG 9.8(6.2-13.6)
IgA 1.8 (0.7-2.8)
IgM 1.4(0.6-2.2)
* p < 0.05 significantly different from the normal
** p < 0.05 significantly different from the normal
0.10(0.05-0.21)*
33 (17-44)*
2.0 (0.4-4.0)*
0.6 (0.2-2.6)*
0.6(0.0-1.6)*
0.3 (0.2-0.6)
22.5(11.0-32.2)*
4.1 (1.2-16.4)*
1.9 (0.6-5.7)*
subjects.
subjects and the patients with alcoholic
0.10(0.09-0.21)*
36 (20-44)
1.7(1.1-2.4)*
0.7(0.3-1.3)
0.4(0.0-1.7)*
0.3(0.3-0.6)
21.5(11.7-31.6)*
2.5 (0.4-9.7)**
1.7(1.1-4.6)
cirrhosis.
Tab. 3. Serum protein concentrations (g/l) before and six to twelve months following an interposition meso-caval shunt in ten
cirrhotic patients. Mediän and ränge.
Before After
Prealbumin
Albumin
ttrAntiproteinase
Orosomucoid
Haptoglobin
Caeruloplasmin
IgG
IgA
IgM
0.09 (0.03- 0.12)
33
2.1
0.6
0.7
0.4
20.7
(17
(1.0
(0.4
(0.1
(0.2
(13.0
-36)
- 3.6)
- 1.2)
- 1.6)
- 0.6)
-29.6)
3.80 ( 2.30^ 6.20)
1.90( 0.40-^ 4.00)
0.14
38
1.7
0.4
0.1
0.3
18.7
3.54
1.50
(0.06- 0.20)
(31 -42)
(1.0 - 2.1)*
(0.2 - 0.8)*
- 0.8)*
- 0.4)*
-31.3)
(0.1
(0.2
(10.6
(1.90- 7.25)
(0.85- 3.70)
p < 0.05
It has been ppstülated that the hypergammaglobulin-
aemia in liver cirrhosis is caused either by immuni-
zation with gut-derived äiitigeüs whieh bypass the
liver, or by a generalized immunologic hyperreactivity
(13, 14). The "gut antigen concept" implies that a
further increase of serum unmunoglobulins shoüld
pccür following shunt surgery. f bis is, however, not
found in our study, but Prytz et al. in a larger group
of patients with mainly porto-caval shunts described
a small but significant increase 7—9 weeks postop-
eratively (14). The differences between the studies
inight be explained by the different sizes of the study
groups, different postoperative time intervals and also
by different types of shunts. Engelbrecht et al. found
in rats that animals with a porto-caval shunt had a
highly significant rise in -globulins, while rats with
a meso-caval shunt exhibited no -globulin changes.
The authors proposed a liver mechanism regulating
splenic globulin production which is preserved follow-
ing a meso-eaval shunt (15).
In conclusion, we find that a meso-caval shunt in
cirrhotic patients does not produce profound changes
in serum prealbumin, albumin and immunoglobulin
concentrations, whereas all the acute phase reactants
studied are significantly depressed.
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